Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Yuhan Corp. and Green Cross Corp. present ceramide glucosyltransferase inhibitors

June 9, 2021

New mucolipin-1 activators identified at Libra Therapeutics

June 9, 2021

Bayer identifies new PTGER3 antagonists

June 7, 2021

LG Chem discloses new melanocortin MC4 receptor agonists

June 4, 2021

Karolinska announces that Dilafor successfully concluded its phase IIb study of tafoxiparin

June 4, 2021

Crinetics Pharmaceuticals synthesizes new melanocortin MC2 receptor antagonists

June 3, 2021

ADO-09 shown to be superior to insulin aspart in type 1 diabetes patients

June 3, 2021

Diverse cohort expands diabetes genomics

June 2, 2021

SCOHIA advances somatostatin SST5 receptor antagonist SCO-240 into phase I study

May 31, 2021

Enrollment opens in phase IIb study of ARO-APOC3 in severe hypertriglyceridemia

May 31, 2021